Cassava Sciences | PTIE - Capitale Sociale E Riserve

Prezzo Delle Azioni
1.61
Cambio Giornaliero
-0.05 -3.01%
Mensile
-12.02%
Annuale
2.55%
Q2 Previsione
1.69




Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.13B 1.3B 2025-12
Amgen USD 8.66B 961M 2025-12
Biogen USD 18.21B 573.5M 2025-09
Cara Therapeutics USD 27.87M 5.06M 2025-09
Cassava Sciences USD 74.4M 7.16M 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Geron USD 225.87M 22.83M 2025-12
J&J USD 81.19B 358M 2026-03
Merck USD 51.85B 2.79B 2025-09
Novartis USD 46.13B 1.38B 2025-12
Novavax USD -127.75M 28.92M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Roche Holding CHF 33.8B 758M 2025-12